Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Vivos Therapeutics Inc is a medical devices business based in the US. Vivos Therapeutics Inc shares (VVOS) are listed on the NASDAQ and all prices are listed in US Dollars. Vivos Therapeutics Inc employs 170 staff and has a trailing 12-month revenue of around $16.5 million.
Finder Award
eToro
Finder Award
SoFi Invest
| Latest market close | $1.28 |
|---|---|
| 52-week range | $0.34 - $3.69 |
| 50-day moving average | $0.73 |
| 200-day moving average | $1.17 |
| Wall St. target price | $3.17 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-1.02 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.28 from 2023-01-24
| 1 week (2023-01-19) | -14.67% |
|---|---|
| 1 month (2022-12-23) | 168.34% |
| 3 months (2022-10-26) | 71.12% |
| 6 months (2022-07-26) | -5.88% |
| 1 year (2022-01-26) | -47.33% |
|---|---|
| 2 years (2021-01-26) | -82.07% |
| 3 years (2020-01-22) | N/A |
| 5 years (2018-01-22) | N/A |
| Revenue TTM | $16.5 million |
|---|---|
| Gross profit TTM | $12.6 million |
| Return on assets TTM | -53.57% |
| Return on equity TTM | -118.84% |
| Profit margin | -152.71% |
| Book value | $0.43 |
| Market capitalisation | $37.5 million |
TTM: trailing 12 months
We're not expecting Vivos Therapeutics Inc to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Vivos Therapeutics Inc's shares have ranged in value from as little as $0.341 up to $3.69. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Vivos Therapeutics Inc's is 1.314. This would suggest that Vivos Therapeutics Inc's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Vivos Therapeutics Inc's beta into context you can compare it against those of similar companies.
Vivos Therapeutics, Inc. , a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
